Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about Hologic, Inc.
Hologic, Inc. News
Hologic, Inc. Quantitative Score
About Hologic, Inc.
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.
Hologic, Inc. Earnings & Revenue
What’s This Company Really Worth? Find Out Instantly.
Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.
Hologic, Inc. Financials
Table Compare
Compare HOLX metrics with: | |||
|---|---|---|---|
Earnings & Growth | HOLX | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | HOLX | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | HOLX | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | HOLX | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
Hologic, Inc. Income
Hologic, Inc. Balance Sheet
Hologic, Inc. Cash Flow
Hologic, Inc. Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
| Metrics | Score |
|---|---|
| Discounted Cash Flows | Strong Buy |
| Return on Equity | Buy |
| Return on Assets | Strong Buy |
| Debt/Equity Ratio | Strong Sell |
| Price/Earnings Ratio | Sell |
| Price/Book Ratio | Sell |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Historical Market Cap
Shares Outstanding
Hologic, Inc. Executives
| Name | Role |
|---|---|
| Mr. Stephen P. MacMillan | Chairman, Chief Executive Officer & President |
| Mr. Jan Verstreken | Group President of International |
| Ms. Karleen M. Oberton CPA | Chief Financial Officer |
| Mr. Essex D. Mitchell | Chief Operating Officer |
| Ms. Monica Aguirre Berthelot | Vice President & Chief of Staff |
| Name | Role | Gender | Date of Birth | Pay |
|---|---|---|---|---|
| Mr. Stephen P. MacMillan | Chairman, Chief Executive Officer & President | Male | 1964 | 3.74M |
| Mr. Jan Verstreken | Group President of International | Male | 1968 | 1.53M |
| Ms. Karleen M. Oberton CPA | Chief Financial Officer | Female | 1970 | 1.52M |
| Mr. Essex D. Mitchell | Chief Operating Officer | Male | 1981 | 1.51M |
| Ms. Monica Aguirre Berthelot | Vice President & Chief of Staff | Female | -- |
Hologic, Inc. Insider Trades
| Date | 30 May |
| Name | Schnittker Brandon |
| Role | Div. President, GYN Surgical |
| Transaction | Disposed |
| Type | F-InKind |
| Shares | 69 |
| Date | 7 May |
| Name | Madaus Martin D |
| Role | Director |
| Transaction | Acquired |
| Type | P-Purchase |
| Shares | 5445 |
| Date | 1 May |
| Name | Liddy Anne M. |
| Role | General Counsel |
| Transaction | Disposed |
| Type | |
| Shares | 0 |
| Date | 1 May |
| Name | Liddy Anne M. |
| Role | General Counsel |
| Transaction | Disposed |
| Type | |
| Shares | 6016 |
| Date | 1 May |
| Name | Liddy Anne M. |
| Role | General Counsel |
| Transaction | Disposed |
| Type | |
| Shares | 7479 |
| Date | Name | Role | Transaction | Type | Shares |
|---|---|---|---|---|---|
| 30 May | Schnittker Brandon | Div. President, GYN Surgical | Disposed | F-InKind | 69 |
| 7 May | Madaus Martin D | Director | Acquired | P-Purchase | 5445 |
| 1 May | Liddy Anne M. | General Counsel | Disposed | 0 | |
| 1 May | Liddy Anne M. | General Counsel | Disposed | 6016 | |
| 1 May | Liddy Anne M. | General Counsel | Disposed | 7479 |